HOTH Stock Analysis: Buy, Sell, or Hold?
HOTH - Hoth Therapeutics, Inc. Common Stock
$0.56
0.01 (2.65%)
▲
5d:
-33.02%
30d:
-45.45%
90d:
-43.24%
WAIT
LOW Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: Mar 27, 2026
0d
Get Alerted When HOTH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: HOTH is down 33.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: HOTH is down 33.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: HOTH is currently trading at $0.56, which is considered oversold relative to its 30-day fair value range of $0.81 to $1.08.
Technical Outlook: Technically, HOTH is in a downtrend. Immediate support is located at $0.50, while resistance sits at $0.95.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $5.00 (+789.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, HOTH is in a downtrend. Immediate support is located at $0.50, while resistance sits at $0.95.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $5.00 (+789.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$0.81 -
$1.08
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 789.8% below Wall St target ($5.00)
- WARNING: Recommendation downgraded due to -33.0% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$0.81 -
$1.08
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$0.50
Resistance Level
$0.95
Current Trend
Downtrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.80
Wall Street Target
$5.00
(+789.8%)
Share & Embed Analysis
Last updated: April 03, 2026 4:58 AM ET
Data refreshes hourly during market hours. Next update: 5:58 AM
Data refreshes hourly during market hours. Next update: 5:58 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HOTH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$873 | 58 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 59 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$94 | 56 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$224 | 60 HOLD |
|
IRON
Disc Medicine Inc. |
STRONG BUY
11 analysts |
$100 | 59 HOLD |
